COVID-19: A Potent Reminder of the Challenge of Emerging Infectious Diseases
The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the…
National Institute of Allergy and Infectious Diseases News
Clinical Trial of Antiviral Remdesivir to Treat COVID-19 Underway
Study Enrolling Hospitalized Adults with COVID-19 in Nebraska A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in…
Research Underway to Address Threat of Novel Coronavirus That Recently Emerged in China
The new cluster of viral pneumonia cases originating in Wuhan, China, marks the third time in 20 years that a member of the large family…
FDA Approved Drug Reverses Signs of Liver Disease in People Living With HIV
Tesamorelin prevented progression to liver fibrosis in NIH study. Researchers at the National Institutes of Health and their colleagues at Massachusetts General Hospital (MGH) in…
Does Oral Immunotherapy for Peanut Allergy Work & What Happens When You Stop?
Few people with peanut allergy tolerate peanut after stopping oral immunotherapy. Continuing with a modest dose confers more protection, NIH-funded study finds. Allergy to peanut,…
NIAID: Sexually Transmitted Infections a Growing Global Health Crisis
Sexually transmitted infections, or STIs, pose a significant public health challenge. Globally, more than one million new STI cases are diagnosed each day. In a…
